COMMUNIQUÉS West-GlobeNewswire

Angel Yeast Co., Ltd. signs exclusive global licence agreement with Renaissance BioScience Corp. for wine, cider and craft beer yeast
18/01/2018
YICHANG, China and VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Angel Yeast Co., Ltd., a Shanghai Stock Exchange listed company (SSE:600298), has signed a global licence agreement with Renaissance [...]
Melinta Therapeutics Announces Initiation of Program for Radezolid in Patients with Bacterial Vaginosis
18/01/2018
NEW HAVEN, Conn., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]
THC Therapeutics becomes Millennium Blockchain
18/01/2018
LAS VEGAS, Jan. 18, 2018 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (“THCT” or the “Company,”) (OTC:THCT) is pleased to announce that it is changing its direction to blockchain technology. The Company is changing its [...]
Purepoint Uranium Reports on First Seven Holes at Hook Lake, Extending Spitfire Strike Length by 25%
18/01/2018
TORONTO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Purepoint Uranium Group Inc. (the “ Company ” or “ Purepoint ”) (TSX.V:PTU) today reported the completion of the first seven holes of the 2017/2018 Winter drill program at the [...]
Diffusion Pharmaceuticals Announces $12 Million Underwritten Public Offering
18/01/2018
CHARLOTTESVILLE, Va., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN ) (“Diffusion” or the “Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]
Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars
18/01/2018
Collaboration aims to help patients worldwide gain access to a range of high-quality, affordable immunology and oncology biologics Partnership will be an important part of Sandoz and Biocon strategy to address the next [...]
Ossur Hf : Q4/FY 2017 Results - Conference call Tuesday 6 February at 9:00 CET
18/01/2018
Announcement from Össur hf. no: 4/2018 Conference call on Tuesday 6 February at 9:00 CET / 8:00 GMT / 3:00 EDT After market closing on Monday 5 February, Össur will publish its financial results for Q4 and the full year [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
18/01/2018
FIT Biotech Oy Company release January 18, 2018 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company
18/01/2018
Oslo (Norway), 18 January 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that they are extending the preclinical research collaboration with an undisclosed top-10 pharma [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
18/01/2018
REGULATED INFORMATION GHENT, Belgium, 18 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
18/01/2018
REGULATED INFORMATION GHENT, Belgium, 18 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
MDxHealth (R): Develops Blood Test to Guide Precision-Treatment of Castration-Resistant Prostate Cancer Patients
18/01/2018
NEWS RELEASE/REGULATED INFORMATION/ INSIDE INFORMATION Study demonstrates test can add prognostic information on overall survival Earlier assessment of treatment response can help identify resistance sooner Over 233,000 [...]
ASLAN Pharmaceuticals Appoints Stephen Doyle as Head of China
18/01/2018
SINGAPORE , Jan. 18, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN, 6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the [...]
Cannabis Wheaton Income Corp. Announces Closing of $100 Million Private Placement of Convertible Debenture Units
18/01/2018
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") is pleased to announce the closing of its [...]
BeiGene Announces Pricing of $750 Million Public Offering
18/01/2018
CAMBRIDGE, Mass. and BEIJING, China, Jan. 17, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
Paratek Announces Public Offering of Common Stock
17/01/2018
BOSTON, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in [...]
Agios Announces Proposed Offering of Common Stock
17/01/2018
CAMBRIDGE, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO ) today announced that it is offering to sell, subject to market and other conditions, up to $400 million of its common stock [...]
OpGen Announces Execution of Reverse Stock Split
17/01/2018
GAITHERSBURG, Md., Jan. 17, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that it will implement a 1-for-25 reverse stock split of its common stock. The Company filed an amendment to its [...]
Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in Spain
17/01/2018
CRANBURY, N.J. and MADRID, Spain, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ), a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch [...]

Pages